当前位置:首页 - 行情中心 - 永顺生物(920729) - 财务分析 - 现金流量表

永顺生物

(920729)

  

流通市值:6.16亿  总市值:21.92亿
流通股本:7682.50万   总股本:2.73亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金46,525,651.28273,203,456.01199,825,102.97128,642,442.98
  收到其他与经营活动有关的现金4,201,816.484,013,556.013,579,364.952,419,988.4
  经营活动现金流入小计50,727,467.76277,217,012.02203,404,467.92131,062,431.38
  购买商品、接受劳务支付的现金18,481,732.0362,754,107.7341,205,947.0127,943,282.6
  支付给职工以及为职工支付的现金17,108,843.7255,144,709.9542,751,436.7730,290,976.77
  支付的各项税费3,984,887.611,499,951.038,651,592.287,035,510.61
  支付其他与经营活动有关的现金10,862,413.8347,785,547.936,133,852.8822,442,105.43
  经营活动现金流出小计50,437,877.18177,184,316.61128,742,828.9487,711,875.41
  经营活动产生的现金流量净额289,590.58100,032,695.4174,661,638.9843,350,555.97
二、投资活动产生的现金流量:
  收回投资收到的现金186,166,395.15361,108,866.91311,473,424.09227,812,633.19
  处置固定资产、无形资产和其他长期资产收回的现金净额-1,600--
  投资活动现金流入小计186,166,395.15361,110,466.91311,473,424.09227,812,633.19
  购建固定资产、无形资产和其他长期资产支付的现金238,2006,980,695.54,029,405.51,422,859.5
  投资支付的现金162,000,000450,559,800.4380,759,800.4273,159,800.4
  投资活动现金流出小计162,238,200457,540,495.9384,789,205.9274,582,659.9
  投资活动产生的现金流量净额23,928,195.15-96,430,028.99-73,315,781.81-46,770,026.71
三、筹资活动产生的现金流量:
  取得借款收到的现金495,984.321,331,613.621,331,613.621,331,613.62
  收到其他与筹资活动有关的现金-14,182,80014,182,80014,182,800
  筹资活动现金流入小计495,984.3215,514,413.6215,514,413.6215,514,413.62
  分配股利、利润或偿付利息支付的现金-35,535,50035,535,50035,535,500
  支付其他与筹资活动有关的现金157,695.18630,924.8474,034.86319,206.28
  筹资活动现金流出小计157,695.1836,166,424.836,009,534.8635,854,706.28
  筹资活动产生的现金流量净额338,289.14-20,652,011.18-20,495,121.24-20,340,292.66
四、汇率变动对现金及现金等价物的影响-324,759.84-153,330.4331,809.41104,841.04
五、现金及现金等价物净增加额24,231,315.03-17,202,675.19-19,117,454.66-23,654,922.36
  加:期初现金及现金等价物余额19,237,898.9936,440,574.1836,440,574.1836,440,574.18
  期末现金及现金等价物余额43,469,214.0219,237,898.9917,323,119.5212,785,651.82
补充资料:
  净利润-41,257,977.62-19,720,898.19
  资产减值准备-1,428,271.68-1,283,852.91
  固定资产和投资性房地产折旧-29,847,539.16-15,170,877.45
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-29,847,539.16-15,170,877.45
  无形资产摊销-3,417,950.33-1,458,282
  长期待摊费用摊销-255,874.63-71,578.98
  固定资产报废损失-25,482.94-8,223.86
  公允价值变动损失--196,719.6--124,881.69
  财务费用-269,039.23--55,786.55
  投资损失--12,251,556.96--5,288,037.98
  递延所得税-487,459.63-137,785.13
  其中:递延所得税资产减少-339,323.34--249,787.32
    递延所得税负债增加-148,136.29-387,572.45
  存货的减少--6,239,013.96-670,613.89
  经营性应收项目的减少-32,521,505.62-6,300,526.17
  经营性应付项目的增加-1,193,449.95--668,575.4
  其他-8,694,693.54-4,343,939.52
  现金的期末余额-19,237,898.99-12,785,651.82
  减:现金的期初余额-36,440,574.18-36,440,574.18
  现金及现金等价物的净增加额--17,202,675.19--23,654,922.36
公告日期2026-04-282026-04-282025-10-282025-08-26
审计意见(境内)标准无保留意见
TOP↑